Doug Fulling’s Post

Thank you MM+M for profiling Precision AQ and our focus on enabling access to life-changing medicines for all.

$2.6B and counting raised since January 2024. If you are a biotech/pharma company looking for a partner to help you secure funding or go public, look no further than Precision AQ - Investor Relations & External Communications.

As we move forward in our mission to enable access to life-changing medicines for ALL, it is essential to highlight the significance of the word ALL, especially during Pride month. At Precision AQ, we value every patient's unique journey, regardless of their gender, race, or sexual orientation. Understanding and embracing these differences is critical and it unites us in our shared humanity. By prioritizing inclusivity, not only do we enrich the lives of those we serve but we also find profound meaning in our work.   #PrideMonth #Inclusivity #Humanity #Diversity #PrecisionAQ

It was truly a pleasure chatting with the Houlihan Lokey team, diving into our rebrand and our mission to empower access to life-changing medicine for all. As I leave American Society of Clinical Oncology (ASCO) today, I feel even more inspired to rally our team of experts, advisors, and creators to dismantle access barriers across payers, providers, and, most importantly, for patients in the oncology community. Precision AQ

Thank you Larry Dobrow and MM+M for covering our rebrand. We are excited launch Precision AQ, which brings our collective capabilities and solutions in marketing, market access, HEOR, investor relations and analytics to enable access to life-changing medicines for all.

Yesterday marked our first official day as Precision AQ, a new name and brand unifying nine organizations to streamline access to our global expertise and services.    In 2023, we supported launches for 57% of all FDA-approved drugs, showcasing our unparalleled skill and scale. United, we’re stronger and more prepared to empower access to life-changing medicine for all.   Precision AQ, standing for “Access Quotient,” combines science (IQ) and empathy (EQ) to navigate the therapy-to-patient journey. We eliminate barriers, providing comprehensive support through data and technology solutions, market access strategy, HEOR, medical communications, and more.   Excited for you to join us on this transformative journey! #accessforall #strongertogether Precision AQ

Thank you Med Ad News and Maria Fontanazza for covering our rebrand announcement.

Today we fulfill the promise that began in 2012 when our company was founded. We have been purpose built, bringing together the best commercialization services and products the industry has to offer. And, today, we unite the Precision Value & Health family of brands as Precision AQ.   Our mission at Precision AQ is clear – to ensure patients have access to the life-changing therapies they need. Our 1200 experts represent the full commercialization continuum, bringing a comprehensive understanding of each individual and every unique need along the way. Our distinct and collaborative approach fuses scientific rigor with the deepest human empathy.   Where IQ meets EQ, we are Precision AQ. Precision Value & Health PRECISIONeffect PRECISIONvalue PRECISIONadvisors PRECISIONheor PRECISIONscientia Makara Health Communications PRECISIONxtract Across Health Precision AQ - Investor Relations & External Communications Precision AQ